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Abstract
With advancing age, skeletal muscle function declines as a result of strength loss. These strength deficits
are largely due to reductions in muscle size (i.e., quantity) and its intrinsic force-producing capacity (i.e.,
quality). Age-induced reductions in skeletal muscle quantity and quality can be the consequence of several
factors, including accumulation of reactive oxygen and nitrogen species (ROS/RNS), also known as
oxidative stress. Therefore, the purpose of this mini-review is to highlight the published literature that has
demonstrated links between aging, oxidative stress, and skeletal muscle quantity or quality. In particular,
we focused on how oxidative stress has the potential to reduce muscle quantity by shifting protein balance
in a deficit, and muscle quality by impairing activation at the neuromuscular junction, excitation-
contraction (EC) coupling at the ryanodine receptor (RyR), and cross-bridge cycling within the myofibrillar
apparatus. Of these, muscle weakness due to EC coupling failure mediated by RyR dysfunction via
oxidation and/or nitrosylation appears to be the strongest candidate based on the publications reviewed.
However, it is clear that age-associated oxidative stress has the ability to alter strength through several
mechanisms and at various locations of the muscle fiber.
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AGING RESULTS IN STRENGTH deficits that are associated with frailty, loss of independence, and physical
disability (40, 51, 64). For instance, adults with low muscle strength have an ∼2- to 4-fold greater risk of
severe mobility limitations, slow gait speed, and mortality compared with older adults with high muscle
strength (38). Reductions in strength are primarily due to changes in skeletal muscle size (i.e., quantity)
(22) and its intrinsic force-producing capacity (i.e., quality) (23, 36, 56). Within the context of aging, loss
of muscle quantity (i.e., atrophy) is referred to as sarcopenia (53, 54), while loss of muscle strength is
termed dynapenia (11, 12, 37). Although sarcopenia contributes to dynapenia, several reports have
demonstrated strength deficits with aging are more rapid than the concomitant loss of muscle size (18, 55),
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which has led some to suggest muscle quantity plays a relatively minor role in dynapenia compared with
muscle quality (11, 12, 37).
Nonetheless, because skeletal muscle quantity and quality both contribute to dynapenia, it is vital to
understand their underlying causes. Sarcopenia is the result of reduced fiber size and number, which
translates into fewer myofibrillar proteins to generate force. In general, loss of muscle quantity with age
includes any factor that alters protein synthesis and/or degradation (e.g., via inflammation, hormonal
content, and nutritional status) or influences the number of functional alpha motor neurons (e.g., via
apoptosis, neurotoxicity) that innervate the muscle (19, 42, 76). On the other hand, muscle quality is
reduced by any factor that lowers force production relative to muscle size or cross-sectional area (CSA),
which can be observed by assessing specific force or tension (56). The mechanisms undermining muscle
quality are largely linked to neurological and skeletal muscle properties (11, 12, 37, 56). Age-associated
neurological properties include changes within the nervous system that impair voluntary activation of the
muscle, such as excitatory drive to the lower motor neurons and/or α-motor neuron excitability (12, 13, 56).
Skeletal muscle property alterations are inherent to the muscle fibers and include age-related changes in
fiber architecture/composition, the excitation-contraction (EC) coupling processes and cross-bridge
mechanics (11, 12, 37, 56).
Accumulation of reactive oxygen and nitrogen species (ROS/RNS) is thought to be a common determinant
in the loss of both muscle quantity and quality (24). With advancing age, the muscle's ability to handle
increased levels of ROS/RNS is compromised (29), which ultimately impairs cellular homeostasis.
Together, this process is commonly referred to as oxidative stress. Accumulation of ROS/RNS can result in
redox modifications to nucleic acids, lipids, and proteins that result in macromolecular damage and/or
dysfunction. However, until recently, the mechanistic relationship between age-induced oxidative stress and
loss of muscle strength was relatively unclear. Therefore, the purpose of this mini-review is to highlight the
published literature that has demonstrated links between aging, oxidative stress, and skeletal muscle
quantity or quality. In particular, we focused specifically on how oxidative stress has the potential to reduce
muscle quantity by shifting protein balance in a deficit and muscle quality by impairing activation at the
neuromuscular junction, EC coupling at the ryanodine receptor (RyR), and cross-bridge cycling within the
myofibrillar apparatus.
ROS/RNS Production and Protein Modification
Under conditions of oxidative stress, the formation of superoxide (O ) and nitric oxide (NO) exceeds their
removal. These free radicals are commonly referred to as primary ROS/RNS, which can also convert to
secondary ROS/RNS, such as hydrogen peroxide (H O ) and peroxynitrite (ONOO ) (28, 47). There are
many sources of ROS/RNS, including the mitochondria, cytosol, and membranes. In skeletal muscle, O
is generated from complexes I and III of the electron transport chain in the mitochondria, in addition to
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase located in the sarcoplasmic reticulum (SR)
and transverse-tubules (T-tubules), and xanthine oxidase located in the endothelium (47). Nitric oxide (NO)
is synthesized from various isoforms of nitric oxide synthase (NOS), including endothelial (eNOS),
neuronal (nNOS), and inducible (iNOS) found throughout the cell (63).
Exposure to ROS/RNS can result in posttranslational modification to the side chains of various proteins,
ultimately affecting their structure and function. These ROS/RNS-induced modifications include nitration,
nitrosylation, carbonylation, and glycation. Nitration and nitrosylation are both NO-dependent
modifications. Specifically, when tyrosine residues are modified, 3-nitrotyrosine (3-NT) is formed, while
nitrosylation occurs when cysteine residues are modified (39). Carbonylation is the most common protein
modification that takes place in the presence of oxidative stress. In this process, carbonyl (C=O) groups are
introduced into proteins by direct metal-catalyzed oxidation of certain amino acids or indirectly by reaction
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4-hydroxynonenal (HNE) (15). Lastly, protein glycation is involved in the formation of advanced glycation
end products (AGEs), which is the addition of a sugar to a protein or lipid. Protein glycation is an emerging
marker of oxidative stress due to the fact that AGE formation significantly increases in the presence of
ROS (45, 46).
Oxidative stress can be prevented by neutralizing ROS/RNS via the antioxidant system. The antioxidant
system includes both endogenous and exogenous molecules. Some endogenous antioxidants include
enzymes like glutathione peroxidase, superoxide dismutase, and catalase, while exogenous antioxidants
include vitamins (e.g., vitamin E and vitamin C) and minerals (zinc, copper, iron) (47). Importantly, these
antioxidants assist in maintaining the redox environment of the muscle and attenuate ROS/RNS-induced
posttranslational modifications.
With aging, oxidative stress is thought to occur due to an overproduction of ROS/RNS and an impaired
ability to neutralize them (29, 66). ROS/RNS production increases with aging due to mitochondrial
dysfunction caused by age-related mitochondrial DNA mutations, deletions (10, 21), and damage (25, 59).
Along with the increase in ROS/RNS production, many of the muscle's antioxidants are also increased,
although this is not a universal response (31). Thus, the burden of defending against ROS/RNS production
may be greater than the compensatory change in the antioxidant system (66). Under these conditions,
ROS/RNS accumulate, causing oxidative stress.
Skeletal Muscle Contraction
To generate a muscle contraction (Fig. 1), the fiber first needs to be activated. In general, this encompasses
the release of acetylcholine (ACh) (i.e., a neurotransmitter) from the presynaptic terminal of the α-motor
neuron at the neuromuscular junction. The ACh transverses the synaptic cleft where it binds to nicotinic
ACh receptors located on the postsynaptic motor endplate of the muscle fiber, which, in turn, generates an
action potential on the surface of the sarcolemma.
From this point, the action potential propagates along the sarcolemma down the T-tubules. Depolarization
of the membrane stimulates the voltage-sensitive dihydropyridine receptors (DHPRs) located in the
T-tubules, which, in turn, activate the ryanodine receptors (RyRs). The RyR is a Ca  release channel
composed of four monomers embedded in the SR membrane. Each RyR monomer interacts with numerous
ancillary proteins and is vulnerable to posttranslational modification. These RyR modifications and
interactions are known to influence channel function, both positively and negatively and, thus, SR Ca
release (5, 73). In this review, we refer to the aforementioned sequence of events (i.e., membrane
depolarization to the release of Ca  from the SR) as EC coupling.
Successful activation of the RyR results in a rise of cytoplasmic Ca  that is sufficient to increase Ca
binding to troponin C, which exposes specific active sites on the actin filaments. These active sites are
specific for actin-myosin interactions. Importantly, actin and myosin transition between two structural
states, strong and weak, which are coupled with ATP hydrolysis. Specifically, binding of ATP to myosin is
a weak structural state and with no force production. Upon hydrolysis and the release of phosphate (a
byproduct of ATP hydrolysis) myosin is in a strong structural state, which generates force. Thus, with
continuous ATP binding and hydrolysis, cyclic interactions of actin and myosin occur resulting in the
sliding of actin filaments past myosin filaments toward the center of the sarcomere. As a whole, we refer to
this process as cross-bridge cycling.
ROS/RNS and Muscle Quantity
Because of increased levels of oxidative stress in aged muscle, ROS/RNS accumulation has been suggested
to play a key role in sarcopenia (24, 41) (Fig. 1). Evidence for this is largely supported by investigations
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of muscle mass can be attenuated by antioxidant supplementation (60). However, within the published
literature, there is evidence for and against these claims.
For instance, it was reported that total protein carbonyl levels and sarcoplasmic, myofibrillar, and
mitochondrial 3-NT content were correlated with muscle mass within aging mice (70) and rats (43),
respectively. In contrast, others failed to find correlations between carbonyl levels in the sarcoplasmic,
myofibrillar and mitochondrial protein fractions and loss of muscle mass in aging rats (43) and humans
(72). Mixed results have also been observed after antioxidant supplementation. For example, long-term
antioxidant supplementation with FI (a cysteine-based antioxidant) (60) and resveratrol (27) were both
shown to reduce markers of oxidative stress in aging mice muscle. Specifically, FI increased the muscle's
glutathione to glutathione disulfide ratio, resveratrol lowered the concentration of H O , while both
alleviated lipid peroxidation. Despite these changes, only supplementation of FI proved beneficial in
preserving muscle quantity, as assessed by muscle weight and CSA (60). Taken together, it appears that
age-related muscle loss may be linked to the accumulation of specific ROS/RNS markers rather than
“oxidative stress” overall. Moreover, it must be remembered that proteins are constantly being degraded
and synthesized, and thus, if markers of oxidative stress are assessed at a single point in time, it would only
provide a snapshot of a relatively dynamic process.
If age-induced ROS/RNS accumulation results in sarcopenia, the effects are likely mediated by shifting
protein balance in a deficit, specifically increasing proteolysis. Although the precise mechanisms
responsible for this process are unclear in old muscle, they may be comparable to those observed following
prolonged periods of contractile inactivity. As reviewed by Powers et al. (48, 49), ROS production can
promote protein breakdown by upregulating components of the ubiquitin-proteasome system and/or
through allosteric activation of muscle proteases (i.e., caspases, calpains). Similar to that of prolonged
inactivity, aging is also associated with greater proteasome expression/content (2), and caspase (8) and
calpain activity (16), which may be linked to ROS/RNS production. It is also feasible that increased
ROS/RNS production could contribute to sarcopenia by impeding muscle protein synthesis. Obviously,
more data are needed to validate whether aged-induced oxidative stress decreases muscle quantity and if so,
by what underlying mechanism(s).
ROS/RNS and Muscle Quality
As mentioned earlier, strength deficits with aging are more rapid than the concomitant loss of muscle
quantity, which suggests dynapenia is largely due to changes in muscle quality. Age-induced ROS/RNS
accumulation has been proposed to impair muscle quality at various locations. These include muscle fiber
activation at the neuromuscular junction, EC coupling at the RyR, and cross-bridge cycling within the
myofibrillar apparatus (Fig. 1).
Muscle fiber activation.
At the neuromuscular junction, ROS production was recently demonstrated to be greater in the levator auris
longus muscle in old mice compared with young mice (26). Interestingly, these changes were associated
with less neurotransmitter being released at the synaptic cleft, which could cause failure in the generation
of an action potential by the sarcolemma. However, in that study, the old muscle appeared to compensate or
offset these changes by becoming more excitable (26). Clearly, this is an understudied area of research, and
future investigations will be needed to determine whether age-induced oxidative stress at the
neuromuscular junction alters muscle quality; in particular, before the muscle begins to compensate for the
age-related reductions seen in neurotransmitter content. With that said, it is also worth noting that persistent
oxidative stress may alter morphology of the α-motor neuron and the neuromuscular junction, ultimately
resulting in the loss of innervation and fiber number (quantity). For a detailed review of this topic, see Jang
and Van Remmen (30).
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EC coupling.
Theoretically, if any step in the EC coupling pathway is disrupted (i.e., EC coupling failure), voltage-
induced SR Ca  release will be impaired and less cytoplasmic Ca  will be available to bind with troponin
C. Impaired SR Ca  release is associated with reductions in specific force in both rodent (3, 32, 55) and
human models of aging (33). Potential reasons for EC coupling failure include an uncoupling between
DHPR and RyR (17, 32, 74), modifications to the RyR (3, 33, 55), and/or a decrease in DHPR density and
thus the DHPR-RyR ratio (52, 57), although the latter was not observed in recent investigations (26, 33).
Accumulation of ROS/RNS is known to modify or remodel the RyR. With advancing age, the RyR
becomes increasingly oxidized and nitrosylated, which has been shown to promote RyR dysfunction in
both mice (3, 71) and human muscle (33). Interestingly, these redox modifications do not appear to directly
alter RyR function per se, but rather through their effects on the ancillary proteins that are associated with
the channel's activity. One in particular is calstabin (FK506 binding protein, FKBP12), a 12-kDa protein
that normally binds to each RyR monomer, which is thought to stabilize the channel, preventing it from
opening to subconductance states (1, 9). In fast-twitch muscle from aged mice, oxidation and nitrosylation
of RyR depleted the channel of calstabin, diminishing the calstabin-RyR interaction (3, 71). These changes
resulted in “leaky” RyR channels that manifested as increases in single-channel open probability and Ca
spark frequency (3, 71). Under these conditions, SR lumen Ca  content decreases, reducing SR Ca
release, and thus, specific force upon voltage-induced activation. Importantly, RyR dysfunction mediated
by depletion of calstabin is not only observed with aging (3, 55), but also heart failure (58), muscular
dystrophy (6), chronic muscle fatigue (7), and contraction-induced injury (4).
Accordingly, methods used to reduce oxidation and/or nitrosylation of RyR or attenuate the loss of
calstabin have proven beneficial in restoring muscle quality. For instance, in vitro antioxidant treatment of
dithiothreitol (DTT) was able to reverse age-related SR Ca  leak and increase SR Ca  stores from intact
fast-twitch and slow-twitch fibers from old mice (71) and human muscle (33), respectively. Furthermore,
treatment of S107 (i.e., a drug that preserves calstabin-RyR binding) (3) and overexpression of
mitochondrial catalase (71) were both able to stabilize calstabin to RyR, prevent SR Ca  leak, and increase
specific force in EDL muscle from old mice. Taken together, these results demonstrate that age-related
reductions in specific force (i.e., muscle quality) are largely due to EC coupling failure stemming from
redox-induced RyR dysfunction.
Cross-bridge cycling.
In addition to less Ca  released from the SR, accumulation of ROS/RNS has also been suggested to reduce
muscle quality by impairing cross-bridge cycling. This idea is largely supported by age-related reductions
in specific force from human- and rat-permeabilized fibers (14, 23, 65, 67), but also findings that have
observed myofibrillar proteins are redox sensitive (20, 43, 44, 62, 75). Importantly, permeabilized fibers do
not have an intact membrane, which means force generation occurs independently of the EC coupling
process and, therefore, directly reflects the actin-myosin interactions. Thus, the loss of specific force
observed in aged permeabilized fibers would be unrelated to the aforementioned RyR dysfunction.
Age-related reductions in specific force often range from 20 to 30% in both human- and rat-permeabilized
fibers (14, 23, 50, 65, 67) and are associated with defective actin-myosin interactions. More specifically,
there is an overall decline in the fraction of myosin heads in the strong binding, force-generating, structural
state (34, 35, 69, 77), which translates into less force for a given amount of actin and myosin. Loss of
specific force could be due to an accumulation of posttranslationally modified actin and myosin proteins
and/or site-specific modifications of key amino acid residues important to the actin-myosin interaction (66).
However, redox modifications to actin and myosin are quite variable on the basis of investigations that
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and HNE adducts (68), which suggests accumulation of modified actin and myosin proteins is not the main
contributor to age-dependent reductions in permeabilized skeletal muscle fiber quality. Rather, evidence for
site-specific, redox modifications appears to be more promising. For instance, oxidative modifications to
cysteine residues of myosin (not actin) have been shown to increase with age but more importantly, are
thought to reduce efficient cross-bridge cycling by inhibiting actin-activated myosin ATPase activity (50).
Although it is difficult to determine the degree to which these redox modifications influence cross-bridge
cycling, it is likely that they are at least partially responsible for the reductions in specific force observed in
permeabilized fiber experiments. It is also possible that other myofibrillar proteins are redox sensitive and
contribute to age-induced muscle dysfunction. For example, troponin T and myosin-binding protein C were
both found to be increasingly carbonylated in the rectus abdominis of old human subjects (20). However, it
is currently unknown how these modifications would influence force production.
Conclusions
Loss of strength is a common consequence of aging and can be attributed to reductions in both skeletal
muscle quantity and quality. Although numerous factors influence these parameters, protein damage and
dysfunction are commonly accredited to age-related elevations in oxidative stress. Here, we highlighted
several investigations that have focused specifically on aging, oxidative stress, and skeletal muscle quantity
or quality. Taken together, accumulation of ROS/RNS has been reported to affect several components
involved in force generation, including skeletal muscle size, fiber activation, EC coupling, and cross-bridge
cycling (Fig. 1). Of these, EC coupling failure mediated by RyR dysfunction via oxidation and/or
nitrosylation appears to be the strongest candidate based on the publications reviewed. However, it is
clearly evident that age-associated oxidative stress has the ability to alter strength at various sites through
several different redox modifications.
Upcoming investigations should not only focus on whether ROS/RNS modifications increase with age, but
also their structural and functional impact, as measured by skeletal muscle quantity and quality.
Furthermore, new knowledge and the respective technological advancements will allow the analysis of
other potential markers of oxidative stress. In the near future, it is likely we will see a significant increase in
the number of specific redox modifications and how they associate with muscle proteins, ultimately
enhancing our understanding of specific aging phenotypes.
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Fig. 1.
Possible mechanisms by which age-related oxidative stress reduces skeletal muscle quantity and/or quality. Accumulation
of reactive oxygen and nitrogen species (ROS/RNS) in old muscle results in protein modification and/or damage that could
reduce quantity (i.e., fiber size) by shifting protein balance in a deficit, and/or quality by impairing muscle fiber activation
at the neuromuscular junction, excitation-contraction (EC) coupling at the RyR and cross-bridge cycling within the
myofibrillar apparatus. SR, sarcoplasmic reticulum; RyR, ryanodine receptor; DHPR, dihydropyridine receptor.
Articles from Journal of Applied Physiology are provided here courtesy of American Physiological Society
Aging and Exercise: Age-induced oxidative stress: how does it in... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142250/?repor...
12 of 12 11/5/19, 2:20 PM
